Vantage Consulting Group’s Cigna CI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-558
Closed -$203K 196
2024
Q1
$203K Sell
558
-166
-23% -$54.6K 0.13% 191
2023
Q4
$217K Buy
+724
New +$212K 0.15% 177
2023
Q3
Sell
-740
Closed -$208K 204
2023
Q2
$208K Buy
+740
New +$193K 0.12% 193
2023
Q1
Sell
-621
Closed -$206K 233
2022
Q4
$206K Sell
621
-128
-17% -$40.5K 0.12% 192
2022
Q3
$208K Sell
749
-54
-7% -$15.2K 0.12% 180
2022
Q2
$212K Sell
803
-57
-7% -$14.7K 0.12% 180
2022
Q1
$206K Sell
860
-167
-16% -$39.1K 0.08% 203
2021
Q4
$236K Buy
1,027
+15
+1% +$3.19K 0.06% 191
2021
Q3
$203K Sell
1,012
-113
-10% -$24.6K 0.04% 190
2021
Q2
$267K Buy
+1,125
New +$281K 0.05% 98
2021
Q1
Sell
-613
Closed -$128K 383
2020
Q4
$128K Buy
+613
New +$120K 0.01% 101

Other funds holding CI

Vantage Consulting Group's CI Position: Q2 2024 in Review

Vantage Consulting Group sold out of Cigna (CI) in Q2 2024, closing a stake of 558 shares — an estimated $203K sold.

Vantage Consulting Group first reported a position in CI in Q4 2020 and held it in 11 quarters. The position peaked at $267K in Q2 2021. 1,664 funds tracked by Wall St. Rank hold CI as of Q2 2024.

  • Vantage Consulting Group reported no remaining Cigna position as of Q2 2024 after selling out during the quarter.
  • Vantage Consulting Group sold 558 Cigna shares in Q2 2024, an estimated $203K.
  • Vantage Consulting Group first reported a position in Cigna in Q4 2020 and held it in 11 quarters.
  • Vantage Consulting Group's Cigna position peaked at $267K in Q2 2021.
  • 1,664 funds tracked by Wall St. Rank held Cigna as of Q2 2024.

Based on Vantage Consulting Group's 13F filing for Q2 2024, filed 14 Aug 2024.